Literature DB >> 21286628

Biocompatible reduced graphene oxide prepared by using dextran as a multifunctional reducing agent.

Young-Kwan Kim1, Mi-Hee Kim, Dal-Hee Min.   

Abstract

A large-scale, cost-effective, and environmentally friendly synthetic strategy for biocompatible reduced graphene oxide (RGO) by using dextran as a reducing and stabilization agent has been developed. Dextran-coated RGO (D-RGO) was readily soluble in water with high biocompatibility.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21286628     DOI： 10.1039/c0cc05005a

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN： 1359-7345            Impact factor:   6.222


  24 in total

1.  Vasoactive effects of stable aqueous suspensions of single walled carbon nanotubes in hamsters and mice.

Authors:  Mary D Frame; Anthony M Dewar; Sayan Mullick Chowdhury; Balaji Sitharaman
Journal:  Nanotoxicology       Date:  2013-09-30       Impact factor: 5.913

2.  Dose ranging, expanded acute toxicity and safety pharmacology studies for intravenously administered functionalized graphene nanoparticle formulations.

Authors:  Shruti Kanakia; Jimmy D Toussaint; Sayan Mullick Chowdhury; Tanuf Tembulkar; Stephen Lee; Ya-Ping Jiang; Richard Z Lin; Kenneth R Shroyer; William Moore; Balaji Sitharaman
Journal:  Biomaterials       Date:  2014-05-20       Impact factor: 12.479

Review 3.  Graphene-based nanomaterials for bioimaging.

Authors:  Jing Lin; Xiaoyuan Chen; Peng Huang
Journal:  Adv Drug Deliv Rev       Date:  2016-05-24       Impact factor: 15.470

4.  Graphene nanoribbons as a drug delivery agent for lucanthone mediated therapy of glioblastoma multiforme.

Authors:  Sayan Mullick Chowdhury; Cassandra Surhland; Zina Sanchez; Pankaj Chaudhary; M A Suresh Kumar; Stephen Lee; Louis A Peña; Michael Waring; Balaji Sitharaman; Mamta Naidu
Journal:  Nanomedicine       Date:  2014-08-13       Impact factor: 5.307

5.  An electrochemical immunosensor for the prostate specific antigen based on the use of reduced graphene oxide decorated with gold nanoparticles.

Authors:  Parnaz Assari; Amir Abbas Rafati; Azizallah Feizollahi; Roghayeh Asadpour Joghani
Journal:  Mikrochim Acta       Date:  2019-06-29       Impact factor: 5.833

6.  Folate-Mediated Targeted Delivery of Combination Chemotherapeutics Loaded Reduced Graphene Oxide for Synergistic Chemo-Photothermal Therapy of Cancers.

Authors:  Raj Kumar Thapa; Yongjoo Choi; Jee-Heon Jeong; Yu Seok Youn; Han-Gon Choi; Chul Soon Yong; Jong Oh Kim
Journal:  Pharm Res       Date:  2016-08-29       Impact factor: 4.200

7.  Reduction of graphene oxide by resveratrol: a novel and simple biological method for the synthesis of an effective anticancer nanotherapeutic molecule.

Authors:  Sangiliyandi Gurunathan; Jae Woong Han; Eun Su Kim; Jung Hyun Park; Jin-Hoi Kim
Journal:  Int J Nanomedicine       Date:  2015-04-15

Review 8.  The influence of reduced graphene oxide on stem cells: a perspective in peripheral nerve regeneration.

Authors:  Xiangyun Yao; Zhiwen Yan; Xu Wang; Huiquan Jiang; Yun Qian; Cunyi Fan
Journal:  Regen Biomater       Date:  2021-06-25

9.  Reduced graphene oxide-silver nanoparticle nanocomposite: a potential anticancer nanotherapy.

Authors:  Sangiliyandi Gurunathan; Jae Woong Han; Jung Hyun Park; Eunsu Kim; Yun-Jung Choi; Deug-Nam Kwon; Jin-Hoi Kim
Journal:  Int J Nanomedicine       Date:  2015-10-05

10.  Physicochemical characterization of a novel graphene-based magnetic resonance imaging contrast agent.

Authors:  Shruti Kanakia; Jimmy D Toussaint; Sayan Mullick Chowdhury; Gaurav Lalwani; Tanuf Tembulkar; Terry Button; Kenneth R Shroyer; William Moore; Balaji Sitharaman
Journal:  Int J Nanomedicine       Date:  2013-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.